Agendia to provide testimony on federal regulation of laboratory developed tests

[News]

Agendia, a world leader in molecular cancer diagnostics, announced today that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting on July 20 in Washington D.C. on the federal regulation of laboratory developed tests (LDTs).

More... (http://www.news-medical.net/news/20100716/Agendia-to-provide-testimony-on-federal-regulation-of-laboratory-developed-tests.aspx)